Home Search Abstracts View Session E-mail Abstract Author


Session 126 Poster Abstracts
Complications of HIV Infection and ART in HIV-Exposed and -Infected Children
Session Day and Time: Wednesday, 1 - 4 pm
Poster Hall


704
Analysis of HIV Tropism in HIV-infected Ugandan Infants
Jessica D. Church*1, W Huang2, J Toma2, L Guay1, F Mmiro3, P Musoke3, J Jackson1, N Parkin2, A Mwatha4, and S Eshleman1
1Johns Hopkins Univ, Baltimore, MD, US; 2Monogram Biosci, South San Francisco, CA, US; 3Makerere Univ, Kampala, Uganda; and 4Fred Hutchinson Cancer Res Ctr, Seattle, WA, US

Background:  HIV-1 may utilize the CXCR4 co-receptor, the CCR5 co-receptor, or both (dual-tropic virus). HIV-1 infection usually initiated with CCR5-using virus. Evolution to CXCR4-using virus is associated with more rapid progression to AIDS. We analyzed HIV-1 tropism in samples from HIV-1-infected Ugandan infants. 

Methods:  Plasma or serum samples (100 µL) collected at 6 to 14 weeks of age were available from 75 of 106 HIV-1-infected Ugandan infants in the HIVNET012 trial who were HIV-infected by 14 weeks of age. HIV tropism was analyzed using a commercial co-receptor tropism assay.  Additional samples were tested from infants who had evidence of CXCR4-using strains, and from their mothers.

Results:  Of 75 samples, 57 (76%) were successfully analyzed. Inability to obtain results on the other 18 samples most likely reflected the low sample volumes available for testing. Of the 57 samples, 52 (91.2%) had the CCR5-using (R5) phenotype, and 5 (8.8%) had evidence of CXCR4-using (X4) virus, including 1 infant with predominantly X4 tropic virus and 4 infants with dual or mixed tropism. Of the 5 infants, 4 were diagnosed with HIV infection at birth, and 1 at 6 to 8 weeks of age. Results from maternal samples collected at delivery, infant samples collected at the time of birth, follow-up samples (available for 2 of 5 infants), and the age at death are shown in the table. The median survival of these 5 infants (24.3 months) was not significantly different from the median survival of the 52 infants who had CCR5-using virus at 6 to 14 weeks of age (23.6 months, log-rank p =0.293). The 2 infants with CXCR4-using virus or dual or mixed tropic virus that used CXCR4 efficiently died within 14.5 months.

Conclusions:  CCR5 tropic virus was detected in the majority of HIV-infected infants at 6 to 14 weeks of age. However, 5 (8.8%) of 57 infants had evidence of infection with either CXCR4-using virus or dual or mixed tropic tropic virus. Further studies are needed to define the tropism of strains in newly infected infants and its effect on disease progression in infants.

 

 

Mother

Infant

 

 

Delivery

Birth

6-8
weeks

14
weeks

12-18
months

Age at death

197

X4

DM

X4

X4

 

14.5 months

185

DM

DM

NA

DM a

 

10.5 months

223

DM

NA b

DM

DM

R5

2.5 years

827

DM

DM

DM

 

DM

2 years

632

R5 c

DM

DM

 

 

4.7 years

 

 

 

 

 

 

 

 

 

 

 

a This sample had a high efficiency of replication in cells with CXCR4.

b HIV infection was diagnosed in this infant at 6 to 8 weeks of age.

c A minor population of dual-tropic clones was identified in this sample.

DM = dual or mixed tropism.